Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 11Ganglioneuroblastoma 5Wilms Tumor 4Rhabdoid Tumor 4Medulloblastoma 4Rhabdomyosarcoma 3Central Nervous System Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Lymphoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Astrocytoma 2Testicular Neoplasms 1Supratentorial Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Retinoblastoma 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pheochromocytoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Optic Nerve Glioma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Nerve Tissue 1

Interventions

Saline Solution 2lonafarnib 1Temozolomide 1Stem Cell Transplantation 1Long-Term Synaptic Depression 1HES 130-0.4 1Dexmedetomidine 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Supratentorial Neoplasms × Stem Cell Transplantation × CNS × Clear all
NCT00179803 2020-08-05

Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 2 Completed
24 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Pinealoma, Supratentorial Neoplasms, Central Nervous System Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡